The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment

Clinica Chimica Acta

Volumn 361, Issue 1-2, 2005, Pages 112-118

  Diepeveen, Sabine H A ^a,c   Verhoeven, Gertie H W E ^a   Van Der Palen, Job ^b   Dikkeschei, Bert L D ^a   Van Tits, Berry L J ^c   Kolsters, Geert ^a   Offerman, Joop J G ^a   Bilo, Henk J G ^a   Stalenhoef, Anton F H ^c  

^a ISALA HOSPITAL   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Dialysis; Lipid profile; Oxidative stress; Prospective cohort study

Indexed keywords

CHOLESTEROL; COPPER; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIALYSIS; DISEASE EXACERBATION; DYSLIPIDEMIA; FEMALE; HEMODIALYSIS; HUMAN; IN VITRO STUDY; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 25644459309     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.05.007     Document Type: Article

References (46)

1. R.N. Foley, and P.S. Parfrey Cardiovascular disease and mortality in ESRD J Nephrol 11 1998 239 245
2. P. Stenvinkel, I. Holmberg, O. Heimburger, and U. Diczfalusy A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
3. B. Canaud, J. Cristol, M. Morena, H. Leray-Moragues, J. Bosc, and F. Vaussenat Imbalance of oxidants and antioxidants in haemodialysis patients Blood Purif 17 1999 99 106
4. J. Himmelfarb, P. Stenvinkel, T.A. Ikizler, and R.M. Hakim The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
5. I. Ceballos-Picot, V. Witko-Sarsat, and M. Merad-Boudia Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure Free Radic Biol Med 21 1996 845 853
6. J. Himmelfarb, E. McMenamin, and E. McMonagle Plasma aminothiol oxidation in chronic hemodialysis patients Kidney Int 61 2002 705 716
7. H. Esterbauer, G. Striegl, H. Puhl, and M. Rotheneder Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Radic Res Commun 6 1989 67 75
8. H.A. Kleinveld, H.L. Hak-Lemmers, A.F. Stalenhoef, and P.N. Demacker Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein Clin Chem 38 1992 2066 2072
9. H.M. Princen, G. van Poppel, C. Vogelezang, R. Buytenhek, and F.J. Kok Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking Arterioscler Thromb 12 1992 554 562
10. C. Wanner Importance of hyperlipidaemia and therapy in renal patients Nephrol Dial Transplant 15 Suppl. 5 2000 92 96
11. P.O. Attman, O. Samuelsson, A.C. Johansson, J.B. Moberly, and P. Alaupovic Dialysis modalities and dyslipidemia Kidney Int Suppl 2003 S110 S112
12. P.O. Attman, O.G. Samuelsson, and J. Moberly Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis Kidney Int 55 1999 1536 1542
13. T. Shoji, Y. Nishizawa, and T. Kawagishi Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis Atherosclerosis 131 1997 229 236
14. D.M. Lee, C. Knight-Gibson, O. Samuelsson, P.O. Attman, C.S. Wang, and P. Alaupovic Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency Kidney Int 61 2002 209 218
15. P. Stenvinkel, I. Holmberg, O. Heimburger, and U. Diczfalusy A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
16. B. Faller, and N. Lameire Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years Nephrol Dial Transplant 9 1994 280 286
17. J. Little, L. Phillips, L. Russell, A. Griffiths, G.I. Russell, and S.J. Davies Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors J Am Soc Nephrol 9 1998 1931 1939
18. P. Stenvinkel, I. Holmberg, O. Heimburger, and U. Diczfalusy A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
19. F. Galli, F. Canestrari, and G. Bellomo Pathophysiology of the oxidative stress and its implication in uremia and dialysis Contrib Nephrol 127 1999 1 31
20. J. Himmelfarb, P. Stenvinkel, T.A. Ikizler, and R.M. Hakim The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
21. F. Locatelli, B. Canaud, K.U. Eckardt, P. Stenvinkel, C. Wanner, and C. Zoccali Oxidative stress in end-stage renal disease: an emerging threat to patient outcome Nephrol Dial Transplant 18 2003 1272 1280
22. P. Stenvinkel, I. Holmberg, O. Heimburger, and U. Diczfalusy A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
23. L.B. Pupim, J. Himmelfarb, E. McMonagle, Y. Shyr, and T.A. Ikizler Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress Kidney Int 65 2004 2371 2379
24. A.K. Cheung Biocompatibility of hemodialysis membranes J Am Soc Nephrol 1 1990 150 161
25. C. Tetta, S. Biasioli, and R. Schiavon An overview of haemodialysis and oxidant stress Blood Purif 17 1999 118 126
26. M. Annuk, B. Fellstrom, O. Akerblom, K. Zilmer, T. Vihalemm, and M. Zilmer Oxidative stress markers in pre-uremic patients Clin Nephrol 56 2001 308 314
27. S.H. Diepeveen, G.H. Verhoeven, and J. van der Palen Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy Nephron Clin Pract 98 2004 c3 c7
28. G.J. Handelman, M.F. Walter, and R. Adhikarla Elevated plasma F2-isoprostanes in patients on long-term hemodialysis Kidney Int 59 2001 1960 1966
29. P. Stenvinkel, I. Holmberg, O. Heimburger, and U. Diczfalusy A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
30. L. Van Tits, J. De Graaf, and H. Hak-Lemmers Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis Lab Invest 83 2003 13 21
31. C.M. Loughrey, I.S. Young, and J. McEneny Oxidation of low density lipoprotein in patients on regular haemodialysis Atherosclerosis 110 1994 185 193
32. J.M. Roob, T. Rabold, and M. Hayn Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD Kidney Int Suppl 78 2001 S128 S136
33. J. Westhuyzen, D. Saltissi, and H. Healy Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls Atherosclerosis 129 1997 199 205
34. Z.A. Massy, and T. Nguyen-Khoa Oxidative stress and chronic renal failure: markers and management J Nephrol 15 2002 336 341
35. R. Vanholder, A. Argiles, and U. Baurmeister Uremic toxicity: present state of the art Int J Artif Organs 24 2001 695 725
36. R. Vanholder, R.D. Smet, G. Glorieux, and A. Dhondt Survival of hemodialysis patients and uremic toxin removal Artif Organs 27 2003 218 223
37. P. Stenvinkel, and P. Barany Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress Nephrol Dial Transplant 17 Suppl. 5 2002 32 37
38. F. Canestrari, U. Buoncristiani, and F. Galli Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients Clin Chim Acta 234 1995 127 136
39. K. Ludat, O. Sommerburg, T. Grune, W.G. Siems, E. Riedel, and H. Hampl Oxidation parameters in complete correction of renal anemia Clin Nephrol 53 2000 S30 S35
40. M.J. Williams, W.H. Sutherland, M.P. McCormick, S.A. De Jong, J.R. McDonald, and R.J. Walker Vitamin C improves endothelial dysfunction in renal allograft recipients Nephrol Dial Transplant 16 2001 1251 1255
41. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
42. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu, and E.J. Topol Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials Lancet 361 2003 2017 2023
43. N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman, and M.J. Mitchinson Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 347 1996 781 786
44. M. Tepel, G.M. van der, M. Statz, J. Jankowski, and W. Zidek The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial Circulation 107 2003 992 995
45. G. Clermont, S. Lecour, and J.F. Cabanne Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients Free Radic Biol Med 31 2001 233 241
46. M. Satoh, Y. Yamasaki, and Y. Nagake Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters Kidney Int 59 2001 1943 1950